This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Centre National De La Recherche Scientifique, Université De Poitiers, Centre Hospitalier Regional Universitaire De Brest. Active years: 2012-2022.
Location History:
- Saint-Pol de Leon, FR (2012)
- Brest, FR (2022)
Company Filing History:
3 out of 5,383 
2 out of 63 
1 out of 1 
Years Active: 2012-2022
Title: Marc Blondel: Innovator in Cancer Treatment and Cystic Fibrosis Research
Introduction
Marc Blondel is a notable inventor based in Saint-Pol de Leon, France. He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for cancers associated with the Epstein-Barr Virus and cystic fibrosis. With a total of 3 patents to his name, Blondel's work exemplifies the intersection of scientific inquiry and practical application.
Latest Patents
One of Marc Blondel's latest patents involves hydrazone derivatives aimed at preventing or treating EBV-related cancers. This invention focuses on novel bis-hydrazone derivatives of a specific formula, which are useful as drugs for treating cancers associated with the Epstein-Barr Virus. Additionally, he has developed a patent concerning the use of guanabenz and its derivatives for creating drugs to treat cystic fibrosis and related diseases. These derivatives are designed to address deficiencies in cellular proteins, showcasing Blondel's commitment to advancing medical science.
Career Highlights
Throughout his career, Marc Blondel has worked with esteemed institutions such as the National Centre for Scientific Research (Centre National De La Recherche Scientifique) and the University of Poitiers (Université De Poitiers). His research has not only contributed to academic knowledge but has also paved the way for practical medical applications.
Collaborations
Marc Blondel has collaborated with notable colleagues, including Rodrigo Prado-Martins and Cécile Voisset. These partnerships have enriched his research endeavors and fostered a collaborative spirit in the scientific community.
Conclusion
Marc Blondel's innovative work in the fields of cancer treatment and cystic fibrosis research highlights his role as a significant contributor to medical science. His patents reflect a dedication to improving health outcomes through scientific innovation.